Latest Revenue Generation News

Kalamazoo Resources Limited reported a cash position of A$1.375 million at the end of September 2025, highlighting ongoing negative cash flows but confidence in securing future funding to sustain operations.

Auric Mining Limited has completed its Jeffreys Find project, initiated production at Munda Gold Mine, and secured the Burbanks processing plant, positioning itself for integrated operations in Western Australia.

VRX Silica Limited has secured critical environmental and mining approvals for its Arrowsmith North silica sand project, alongside binding offtake contracts with major Asian customers, setting the stage for production by late 2026.

Energy World Corporation focused on advancing its capital raising and asset sales in Q3 2025, ending the quarter with $15 million in cash but no revenue generation.

DUG Technology reports a robust start to FY26 with 19% revenue growth and a landmark SaaS and HPCaaS contract, marking key international milestones.

Algorae Pharmaceuticals has broadened its commercial footprint in Australia and New Zealand through key licensing agreements, while advancing its AI-driven drug discovery platform and strengthening leadership.

Murray Cod Australia Ltd reports a robust start to FY26 with a 45% increase in sales and a $17 million capital raise, driven by expanded production and market access including new Halal certification.

Memphasys has signed a pivotal supply agreement with Andro Diagnostics to distribute its Felix™ sperm separation system across over 200 IVF clinics in India, marking a major step in its new global go-direct commercial strategy.

Juno Minerals has completed the sale of its Mount Mason DSO Hematite Project for A$6 million plus a 2% royalty, while maintaining focus on its flagship Mount Ida Magnetite Project.

Javelin Minerals has signed a pivotal Land Use Agreement with the Marlinyu Ghoorlie group and expanded its mining lease application, setting the stage for gold production at the Eureka Project by mid-2026.

Gibb River Diamonds has begun mining at its Edjudina Gold Project in Western Australia, stockpiling high-grade ore and securing a processing deal with Black Cat Syndicate. First cash proceeds are expected by early 2026, marking a pivotal step for the company.

Artrya Limited has secured FDA clearance for its Salix Coronary Plaque module and raised $80 million to fuel its U.S. commercial expansion, marking a pivotal step in its transition from development to revenue generation.